Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Anti-NMDA receptor encephalitis - case report].
Neurologic complications of influenza.
Feedforward postural control in individuals with multiple sclerosis during load release.
Balo's Concentric Sclerosis with Acute Presentation and Co-Existing Multiple Sclerosis-Typical Lesions on MRI.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.
Extracting quantitative measures from EAP: a small clinical study using BFOR.
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study.
Exosomes as a potential novel therapeutic tools against neurodegenerative diseases.
Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab.
The Development and Maintenance of Paclitaxel-Induced Neuropathic Pain Requires Activation of the Sphingosine 1-Phosphate Receptor Subtype 1.
Multiple Sclerosis: Changes in Microarchitecture of White Matter Tracts after Training with a Video Game Balance Board.
Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.
Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Surveillance and medical therapy following endovascular treatment of chronic cerebrospinal venous insufficiency.
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis.

Pages